BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12313870)

  • 41. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium].
    Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI
    J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triphasics and ovarian cysts: no relationship?
    Contracept Technol Update; 1988 Aug; 9(8):89-92. PubMed ID: 12281609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncology patients pose challenge in choosing birth control method.
    Neinstein LS; Katz B
    Contracept Technol Update; 1985 Apr; 6(4):66-8. PubMed ID: 12313869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lyndiol (1 mg)--evaluation of a new low dose oral contraceptive.
    Banerjee SK
    Antiseptic; 1977 Sep; 74(9):531-3. PubMed ID: 12281247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exercise and "the pill": putting a rumor to rest.
    Schelkun PH
    Phys Sportsmed; 1991 Mar; 19(3):143-4, 146, 151-. PubMed ID: 12286895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual disorders after sterilization with special reference to ovarian activity.
    Kishore N; Khambatta R; Mullick S
    J Obstet Gynaecol India; 1972 Apr; 22():180-4. PubMed ID: 12256847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Menstrual bleeding with the pill and the IUD.
    Hefnawi F; Younis N; Zaki K; Rassid SA; Mekkawi T
    IPPF Med Bull; 1970; 4(6):4. PubMed ID: 12254736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OCs: international experts discuss state-of-the-art.
    Contracept Technol Update; 1981 Nov; 2(11):147-51. PubMed ID: 12338027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modern management of secondary amenorrhoea.
    Banerjee S
    Calcutta Med J; 1989; 86(5-6):46-9. PubMed ID: 12284231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Side-effects and possible complications of oral contraceptive drugs.
    Rossi GV
    Am J Pharm; 1966; 138():127-36. PubMed ID: 12255641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective experience with a levonorgestrel implant--Norplant.
    Lopez G; Rodriguiz A
    Contracept Deliv Syst; 1984 Oct; 5(4):293-302. PubMed ID: 12339954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaginal contraceptive film gains wider acceptance.
    Contracept Technol Update; 1992 Sep; 13(9):1-2. PubMed ID: 12317927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breakthrough bleeding number one problem with OC use.
    Contracept Technol Update; 1991 Dec; 12(12):185-90. PubMed ID: 12285219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of oral contraceptives on the ultrastructure of the endometrium.
    Mitra PK; Roychadhuri J
    J Gynaecol Endocrinol; 1987; 3(1-4):13-5. PubMed ID: 12316565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ovarian cysts and minipills (author's transl)].
    Cappielo B
    Contracept Fertil Sex (Paris); 1981 Feb; 9(2):101-7. PubMed ID: 12262315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Contraception and sexuality].
    Kahn-nathan J
    Cah Sexol Clin; 1987; 13(77):58-63. PubMed ID: 12342527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Do's and don'ts concerning an amenorrheic patient after pregnancy termination].
    Achard B
    Contracept Fertil Sex (Paris); 1985 May; 13(5):766. PubMed ID: 12267102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential risks, benefits of progestins in birth control pills outlined.
    Contracept Technol Update; 1984 Jun; 5(6):71. PubMed ID: 12313083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.